What innovative delivery methods could Merck develop for its Gardasil HPV vaccine to increase accessibility and uptake?

Introduction

To increase accessibility and uptake of Merck's Gardasil HPV vaccine, we need to explore innovative delivery methods. This challenge involves considering various stakeholders, understanding barriers to access, and developing creative solutions that leverage technology and partnerships. I'll approach this by analyzing key user segments, identifying pain points, generating solutions, and proposing metrics to measure success.

Step 1

Clarifying Questions (5 mins)

• Looking at the current vaccine distribution landscape, I'm thinking accessibility might vary significantly across different regions and demographics. Could you provide more context on the current distribution channels and any specific geographical or demographic areas where uptake has been particularly challenging?

Why it matters: Helps focus our efforts on the most impactful areas for improvement Expected answer: Distribution primarily through healthcare providers, with lower uptake in rural areas and among certain socioeconomic groups Impact on approach: Would prioritize solutions targeting underserved areas and populations

• Considering the nature of the HPV vaccine requiring multiple doses over time, I'm curious about the current patient adherence rates. Do we have data on the percentage of patients who complete the full vaccination series, and what are the primary reasons for incomplete vaccination?

Why it matters: Identifies if the problem is initial access or long-term adherence Expected answer: 60-70% completion rate, with time constraints and forgetfulness as primary reasons for incompletion Impact on approach: Would focus on solutions that address both initial access and long-term adherence

• Given the sensitive nature of HPV vaccination, especially for younger recipients, I'm wondering about the current perception and awareness levels among different stakeholder groups. What insights do we have on the attitudes of parents, schools, and healthcare providers towards the vaccine?

Why it matters: Helps determine if the problem is more about access or education/perception Expected answer: Mixed perceptions, with some resistance due to misinformation and concerns about promoting sexual activity Impact on approach: Would incorporate strong educational components and targeted messaging in our solutions

• Thinking about potential technological solutions, I'm interested in understanding the current digital health infrastructure in our target markets. What level of smartphone penetration and digital health tool adoption exists among our target users?

Why it matters: Determines the feasibility of tech-based solutions Expected answer: High smartphone penetration in urban areas, growing in rural areas; moderate adoption of digital health tools Impact on approach: Would tailor digital solutions to different levels of tech adoption and explore hybrid digital/physical approaches